IBDEI1XA ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30710,0)
 ;;=E87.3^^123^1583^3
 ;;^UTILITY(U,$J,358.3,30710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30710,1,3,0)
 ;;=3^Alkalosis
 ;;^UTILITY(U,$J,358.3,30710,1,4,0)
 ;;=4^E87.3
 ;;^UTILITY(U,$J,358.3,30710,2)
 ;;=^5003021
 ;;^UTILITY(U,$J,358.3,30711,0)
 ;;=E87.4^^123^1583^24
 ;;^UTILITY(U,$J,358.3,30711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30711,1,3,0)
 ;;=3^Mixed Acid-Base Balance Disorder
 ;;^UTILITY(U,$J,358.3,30711,1,4,0)
 ;;=4^E87.4
 ;;^UTILITY(U,$J,358.3,30711,2)
 ;;=^5003022
 ;;^UTILITY(U,$J,358.3,30712,0)
 ;;=E86.9^^123^1583^31
 ;;^UTILITY(U,$J,358.3,30712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30712,1,3,0)
 ;;=3^Volume Depletion,Unspec
 ;;^UTILITY(U,$J,358.3,30712,1,4,0)
 ;;=4^E86.9
 ;;^UTILITY(U,$J,358.3,30712,2)
 ;;=^332840
 ;;^UTILITY(U,$J,358.3,30713,0)
 ;;=E86.0^^123^1583^6
 ;;^UTILITY(U,$J,358.3,30713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30713,1,3,0)
 ;;=3^Dehydration
 ;;^UTILITY(U,$J,358.3,30713,1,4,0)
 ;;=4^E86.0
 ;;^UTILITY(U,$J,358.3,30713,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,30714,0)
 ;;=E86.1^^123^1583^22
 ;;^UTILITY(U,$J,358.3,30714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30714,1,3,0)
 ;;=3^Hypovolemia
 ;;^UTILITY(U,$J,358.3,30714,1,4,0)
 ;;=4^E86.1
 ;;^UTILITY(U,$J,358.3,30714,2)
 ;;=^332744
 ;;^UTILITY(U,$J,358.3,30715,0)
 ;;=E87.70^^123^1583^11
 ;;^UTILITY(U,$J,358.3,30715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30715,1,3,0)
 ;;=3^Fluid Overload,Unspec
 ;;^UTILITY(U,$J,358.3,30715,1,4,0)
 ;;=4^E87.70
 ;;^UTILITY(U,$J,358.3,30715,2)
 ;;=^5003023
 ;;^UTILITY(U,$J,358.3,30716,0)
 ;;=E87.5^^123^1583^14
 ;;^UTILITY(U,$J,358.3,30716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30716,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,30716,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,30716,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,30717,0)
 ;;=E87.6^^123^1583^20
 ;;^UTILITY(U,$J,358.3,30717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30717,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,30717,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,30717,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,30718,0)
 ;;=E87.8^^123^1583^8
 ;;^UTILITY(U,$J,358.3,30718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30718,1,3,0)
 ;;=3^Electrolyte & Fluid Balance Disorders NEC
 ;;^UTILITY(U,$J,358.3,30718,1,4,0)
 ;;=4^E87.8
 ;;^UTILITY(U,$J,358.3,30718,2)
 ;;=^5003026
 ;;^UTILITY(U,$J,358.3,30719,0)
 ;;=E26.81^^123^1583^5
 ;;^UTILITY(U,$J,358.3,30719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30719,1,3,0)
 ;;=3^Bartter's Syndrome
 ;;^UTILITY(U,$J,358.3,30719,1,4,0)
 ;;=4^E26.81
 ;;^UTILITY(U,$J,358.3,30719,2)
 ;;=^329906
 ;;^UTILITY(U,$J,358.3,30720,0)
 ;;=E23.2^^123^1583^7
 ;;^UTILITY(U,$J,358.3,30720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30720,1,3,0)
 ;;=3^Diabetes Insipidus
 ;;^UTILITY(U,$J,358.3,30720,1,4,0)
 ;;=4^E23.2
 ;;^UTILITY(U,$J,358.3,30720,2)
 ;;=^33572
 ;;^UTILITY(U,$J,358.3,30721,0)
 ;;=E83.41^^123^1583^15
 ;;^UTILITY(U,$J,358.3,30721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30721,1,3,0)
 ;;=3^Hypermagnesemia
 ;;^UTILITY(U,$J,358.3,30721,1,4,0)
 ;;=4^E83.41
 ;;^UTILITY(U,$J,358.3,30721,2)
 ;;=^5003002
 ;;^UTILITY(U,$J,358.3,30722,0)
 ;;=E21.3^^123^1583^17
 ;;^UTILITY(U,$J,358.3,30722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30722,1,3,0)
 ;;=3^Hyperparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,30722,1,4,0)
 ;;=4^E21.3
 ;;^UTILITY(U,$J,358.3,30722,2)
 ;;=^331438
